Add Yahoo as a preferred source to see more of our stories on Google. It’s been said before and it’s true: a healthy scalp is key to healthy hair. But for those dealing with pesky and sometimes ...

WESTLAKE VILLAGE, Calif., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (ARQT) (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful ...

While "seborrheic dermatitis" (seb derm) may not be a household name, one of its most common visible symptoms—flakes that may ...

Please provide your email address to receive an email when new articles are posted on . Malassezia yeast may not be the root cause of seborrheic dermatitis. A new study showed that Zoryve was a ...

Please provide your email address to receive an email when new articles are posted on . A meta-analysis found a global pooled prevalence of 4.38% for seborrheic dermatitis. Overall prevalence in ...

ZORYVE ® (roflumilast) foam 0.3% is a once-daily, steroid-free, leave-in topical foam uniquely formulated to treat the itching, redness, and flaking of seborrheic dermatitis anywhere it appears, ...

Dear Doctors: I have dandruff, and my doctor says it’s from seborrheic dermatitis. Can you explain what that is? I’ve been using the special shampoo I was given, and it helps. When I stop using it, ...

Arcutis Biotherapeutics, Inc. ARQT announced that the FDA has approved the new drug application (NDA) for Zoryve (roflumilast) topical foam 0.3% for the treatment of seborrheic dermatitis in patients ...

If the skin under your facial hair is often red, irritated, itchy or flaky, the culprit could be a condition called seborrheic dermatitis. This is the same condition that causes dandruff on the scalp, ...

TORONTO, Oct. 21, 2024 /CNW/ - Arcutis Canada Inc., a commercial-stage company focused on delivering meaningful innovations in immuno-dermatology, is pleased to announce that Health Canada has ...